Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. November 2015 07:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Announces Data to be Presented at the 2015 AASLD Annual Meeting

NEW YORK, Nov. 3, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel...
02. November 2015 16:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept to Report Third Quarter 2015 Financial Results on November 9th

NEW YORK, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
28. Oktober 2015 07:30 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Announces Results of Phase 2 Trial of OCA in NASH Patients in Japan

NEW YORK, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
28. September 2015 07:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Announces Initiation of REGENERATE Trial for Obeticholic Acid in NASH Patients With Advanced Liver Fibrosis

NEW YORK, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
08. September 2015 07:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept to Present at the Baird Healthcare Conference

NEW YORK, Sept. 8, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
31. August 2015 07:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis

NEW YORK, Aug. 31, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
05. August 2015 16:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Business Update

NEW YORK, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
29. Juli 2015 16:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept to Report Second Quarter 2015 Financial Results on August 5 and Present at Upcoming Conferences

NEW YORK, July 29, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
21. Juli 2015 16:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Appoints Richard Kim as Senior Vice President, Commercial Head of U.S.

NEW YORK, July 21, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
29. Juni 2015 16:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Submits Applications in the U.S. and Europe for Marketing Approval of Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis

NEW YORK, June 29, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...

Vorherige Seite